Article

 

Xanthohumol lowers body weight and fasting plasma glucose in obese male Zucker fa/fa rats Public Deposited

Downloadable Content

Download PDF
https://ir.library.oregonstate.edu/concern/articles/rf55z851t

This is an author's peer-reviewed final manuscript, as accepted by the publisher. The published article is copyrighted by Elsevier and can be found at:  http://www.journals.elsevier.com/phytochemistry/.

Descriptions

Attribute NameValues
Creator
Abstract
  • Obesity contributes to increased risk for several chronic diseases including cardiovascular disease and type 2 diabetes. Xanthohumol, a prenylated flavonoid from hops (Humulus lupulus), was tested for efficacy on biomarkers of metabolic syndrome in 4 week old Zucker fa/fa rats, a rodent model of obesity. Rats received daily oral doses of xanthohumol at 0, 1.86, 5.64, and 16.9 mg/kg BW for 6 weeks. All rats were maintained on a high fat (60% kcal) AIN-93G diet for 3 weeks to induce severe obesity followed by a normal AIN-93G (15% kcal fat) diet for the last 3 weeks of the study. Weekly food intake and body weight were recorded. Plasma cholesterol, glucose, insulin, triglyceride, and monocyte chemoattractant protein -1 (MCP-1) levels were assessed using commercial assay kits. Plasma and liver tissue levels of XN and its metabolites were determined by liquid-chromatography tandem mass spectrometry. Plasma and liver tissue levels of xanthohumol were similar between low and medium dose groups and significantly (p<0.05) elevated in the highest dose group. There was a dose-dependent effect on body weight and plasma glucose levels. The highest dose group (n=6) had significantly lower plasma glucose levels compared to the control group (n=6) in male but not female rats. There was also a significant decrease in body weight for male rats in the highest dose group (16.9 mg / kg BW) compared to rats that received no xanthohumol, which was also not seen for female rats. Plasma cholesterol, insulin, triglycerides, and MCP-1 as well as food intake were not affected by treatment. The findings suggest that xanthohumol has beneficial effects on markers of metabolic syndrome.
Resource Type
DOI
Date Available
Date Issued
Citation
  • Legette, L. L., Luna, A. Y. M., Reed, R. L., Miranda, C. L., Bobe, G., Proteau, R. R., & Stevens, J. F. (2013). Xanthohumol lowers body weight and fasting plasma glucose in obese male zucker fa/fa rats. Phytochemistry, 91, 236-241. doi:10.1016/j.phytochem.2012.04.018
Academic Affiliation
Series
Keyword
Rights Statement
Funding Statement (additional comments about funding)
  • This study was supported by the National Institutes of Health (R21AT005294, S10 RR022589 and P30 ES000210).
Publisher
Peer Reviewed
Language
Replaces
Additional Information
  • description.provenance : Submitted by Deanne Bruner (deanne.bruner@oregonstate.edu) on 2013-10-01T00:34:01Z No. of bitstreams: 1 StevensJanFredPharmacyXanthohumolLowersBody.pdf: 365304 bytes, checksum: ad4606d1e22405cc26c8f457dc4839c8 (MD5)
  • description.provenance : Approved for entry into archive by Deanne Bruner(deanne.bruner@oregonstate.edu) on 2013-10-01T00:35:17Z (GMT) No. of bitstreams: 1 StevensJanFredPharmacyXanthohumolLowersBody.pdf: 365304 bytes, checksum: ad4606d1e22405cc26c8f457dc4839c8 (MD5)
  • description.provenance : Made available in DSpace on 2013-10-01T00:35:17Z (GMT). No. of bitstreams: 1 StevensJanFredPharmacyXanthohumolLowersBody.pdf: 365304 bytes, checksum: ad4606d1e22405cc26c8f457dc4839c8 (MD5) Previous issue date: 2013-07

Relationships

Parents:

This work has no parents.

Items